This workshop was jointly organized by the Malaysian Institute for Nuclear Technology Research (MINT), the National University of Malaysia (Universiti Kebangsaan Malaysia, UKM), University of Malaya Medical Center (UMMC), and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, in cooperation with the Japan Atomic Industrial Forum, Inc. (JAIF). The representatives from 8 FNCA countries, i.e., China, Indonesia, Japan, Republic of Korea, Malaysia, the Philippines, Thailand, and Vietnam, attended the Workshop.
Firstly, the Workshop discussed in detail the status and outcome of ongoing two projects, i.e., CERVIX-1 and CERVIX-2. As to the standardized protocol project (CERVIX-1), the booklet entitled as Radiation Therapy of Stage IIIB Cervical Cancer for Asians Report and Guideline from the Cooperative Group Trial has been published from the Asia Cooperation Center of JAIF. This booklet describes the Standardized Protocol, its procedures and achievements as of the end of year 2001 together with the information on the current status of radiation therapy of uterine cervix cancer in the participating countries.
In the AHF project (CERVIX-2), there was significant progress made in the number of registered cases, 102 in total by the end of year 2001, thanks to the efforts by participating countries. The results are promising with regards to the local control as well as complications, even though the number of registered patients and follow-up period were considerably limited. Participating countries are encouraged to increase the accrued number of patients for this trial to as many as possible. Registration of new patients will continue till the end of this year.
In relation to the quality assurance and quality control (QA/QC) of radiation dosimetry for these clinical trials, Japan reported on her recent experience of the inter-comparison exercise performed on the irradiation equipments and treatment planning systems in the participating countries. While recognizing the importance of this aspect which not only directly affects the quality of current cooperative clinical trial, but also the appropriateness of radiation oncology practices as a whole, and hence the welfare of the patients, the meeting deliberated on this issue in some detail and recommended that more efforts be made in this regard through systematic and comprehensive approach.
The meeting discussed the following themes as the possible subjects of future cooperative clinical studies in order to establish Standardized Protocol.